Patents Examined by D. Faulkner
  • Patent number: 6025384
    Abstract: Tetrahydrofurans, tetrahydrothiophenes, pyrrolidines and cyclopentanes are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. It has been determined that 5-lipoxygenase activity, oral availability, and stability in vivo (for example, glucuronidation rate) can vary significantly among the optical isomers of the disclosed compounds.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: February 15, 2000
    Assignee: LeukoSite, Inc.
    Inventors: Xiong Cai, Aberra Fura, Changgeng Qian
  • Patent number: 6013273
    Abstract: The invention provides a method for the treatment of endotoxic shock comprising administering to a human or other mammal in need of such a treatment an effective amount of choline for reducing endotoxin-induced injury and mortality and a nutritional composition comprising choline, whereby the composition provides a daily dosage of at least 1.5 g choline, the upper limit being 20 g of choline per day.
    Type: Grant
    Filed: January 27, 1997
    Date of Patent: January 11, 2000
    Assignee: Novartis Nutrition AG
    Inventors: Heinz Schneider, Ronald G. Thurman
  • Patent number: 6010708
    Abstract: There are disclosed cosmetics which comprise N-acylamino acids containing acyl groups having specifically numbered carbon atoms, or derivatives thereof and which are well suited for hair growth, skin care and the like; N-acylamino acid compositions which are favorably usable for detergents, dispersants, emulsifying agents, antimicrobial drugs, antiseptics, ultraviolet absorbers and the like. The invention provides cosmetics which comprise N-acylamino acids containing acyl groups having odd-numbered carbon atoms, salts thereof or esters thereof; N-acylamino acid compositions; and further N-acylamino acids containing acyl groups having carbon atoms in an odd number in the range of 13 to 17 along with salts and esters thereof.
    Type: Grant
    Filed: October 23, 1997
    Date of Patent: January 4, 2000
    Assignee: Kashima Oil Company
    Inventors: Kimihiko Ogihara, Hisashi Yamashita, Yoshihiro Takayama, Kazunori Ishigami
  • Patent number: 5980918
    Abstract: A topical composition for healing treatment of burns and wounds and scarring therefrom has as the active ingredient cereal-derived (1-3) (1-4) .beta.-D-glucan at about 0.5-15 w/w percent. The composition may be formulated in various forms with creams and gels being preferred for application to the skin.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: November 9, 1999
    Assignee: Brennen Medical, Inc.
    Inventor: Barbara K. Klein
  • Patent number: 5976565
    Abstract: A patch for topical application of an anti-acne formulation has in various embodiments a backing film, a release layer and at least one adhesive polymeric matrix layer located between the backing film and the release layer. The anti-acne formulation is uniformly distributed throughout one or more polymeric matrix layers and has an anti-acne effective amount of at least two agents selected from the group consisting of an anti-microbial, an antiseptic, an anti-irritant, a keratolytic agent, a hormone, a hormone agonist and a hormone antagonist.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: November 2, 1999
    Assignee: Lavipharm Laboratories, Inc.
    Inventor: Spiros Fotinos
  • Patent number: 5932231
    Abstract: The invention provides high purity branched alkylsilsesquioxane containing fluids of the general formula Me.sub.3 SiO--(Me.sub.3 SiORSiO).sub.x --SiMe.sub.3, wherein Me is methyl, R is a monovalent hydrocarbon substituent, and x is 1 to 6, and an essentially zero waste process for their synthesis in quantitative yield; and especially n-octylsilsesquioxane containing fluids which are structural analogs of phenylsilsesquioxane containing fluids of the general formula Me.sub.3 SiO--(Me.sub.3 SiOPhSiO).sub.x --SiMe.sub.3, wherein Me is methyl, Ph is phenyl, x is 1 to 6, and have substantially identical sensory properties to their phenylsilsesquioxane counterparts.
    Type: Grant
    Filed: July 11, 1997
    Date of Patent: August 3, 1999
    Assignee: PCR, Inc.
    Inventors: Gary E. LeGrow, William I. Latham, III
  • Patent number: 5928664
    Abstract: The present invention provides consumable, gummy delivery systems and methods of making the same. The gummy delivery systems include an active ingredient admixed with a glycerylated gelatin matrix prepared by heating an aqueous solution of gelatin and glycerin to a temperature and for a time sufficient to remove some of the moisture content of the initial aqueous solution. The active ingredient can be delivered from a shearform matrix carrier.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: July 27, 1999
    Assignee: Fuisz Technologies Ltd.
    Inventors: Robert K. Yang, T. Victor Oh
  • Patent number: 5916574
    Abstract: The natural poison skin treatment method of the present invention includes applying to skin a composition including an effective amount of natural poison skin treatment medication selected from the group consisting of benzoyl peroxide and salicylic acid, an effective amount of a vasoconstrictor and an inert carrier. The natural poison skin treatment medication is therapeutic to natural poison skin conditions by acting as an antibacterial agent. The vasoconstrictor removes the redness normally associated with natural poison skin conditions as well as additional redness which may be caused by the benzoyl peroxide itself. The carrier is simply an inert flowing carrier to permit the application of the active ingredients to the skin. In preferred embodiments about 1 to 15% of the natural poison skin treatment medication based on the total weight of the composition is included.
    Type: Grant
    Filed: January 8, 1997
    Date of Patent: June 29, 1999
    Assignee: Ideal Ideas, Inc.
    Inventors: Karen G. Fried, Kenneth P. Glynn
  • Patent number: 5910312
    Abstract: The acne treatment composition of the present invention includes an effective amount of acne treatment medication selected from the group consisting of benzoyl peroxide and salicylic acid, and effective amount of a vasoconstrictor and an inert carrier. The acne treatment medication is therapeutic to acne conditions by acting as an antibacterial agent. The vasoconstrictor removes the redness normally associated with acne conditions as well as additional redness which may be caused by the benzoyl peroxide itself. The carrier is simply an inert flowing carrier to permit application of the active ingredients to the skin. In preferred embodiments about 1 to 15% of the acne treatment medication based on the total weight of the composition is included. The preferred acne treatment medication is benzoyl peroxide and the preferred vasoconstrictor is tetrahydrozoline hydrochloride or a combination of tetrahydrozoline hydrochloride and zinc sulfate.
    Type: Grant
    Filed: October 9, 1996
    Date of Patent: June 8, 1999
    Assignee: Ideal Ideas, Inc.
    Inventor: Karen G. Fried
  • Patent number: 5904933
    Abstract: Stable reverse water-in-fluorocarbon emulsions and water-in-fluorocarbon-in-water multiple emulsions comprising the reverse fluorocarbon emulsions. The reverse emulsions comprise a continuous phase which is a highly fluorinated or perfluorinated compound, a discontinuous aqueous phase and a fluorinated surfactant or mixture of surfactants. The multiple emulsions comprise an aqueous continuous phase and a discontinuous phase comprising globules formed of aqueous droplets dispersed into a highly fluorinated or perfluorinated compound. The emulsions can contain pharmacologically active agents, and are particularly suitable for pulmonary drug delivery.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 18, 1999
    Assignee: Alliance Pharmaceutical Corp.
    Inventors: Jean G. Riess, Marie-Pierre Krafft
  • Patent number: 5888550
    Abstract: Provided are enteric coating compositions which utilize a low viscosity cellulose acetate phthalate polymer as a film former. The cellulose acetate phthalates have an inherent viscosity of about 0.2 to 0.6 dL/g and phthalyl values of from 30 to 40% and can be applied to solid oral medicaments with less solvent than conventional cellulose acetate phthalate polymers. Also provided is a process for preparing the low viscosity cellulose acetate phthalate polymers.
    Type: Grant
    Filed: March 3, 1997
    Date of Patent: March 30, 1999
    Assignee: Eastman Chemical Company
    Inventors: Phillip Michael Cook, Joseph Vaden Smith
  • Patent number: 5888879
    Abstract: A make-up cosmetic product, which enhances the appearance of complexion, is evaluated by irradiating lights having a wavelength range of visible light onto a surface on which the make-up cosmetic product is applied, from at least two directions with different incident angles, measuring a plurality of spectra of reflected lights obtained from the irradiated lights, respectively, and comparing the spectrum patterns with each other. This clarifies the optical theory by which the skin looks beautiful and provides a method for evaluating a make-up cosmetic product making the skin look beautiful.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: March 30, 1999
    Assignee: Pola Chemical Industries Inc.
    Inventors: Kazuhiro Nishikata, Hirochika Nishimura
  • Patent number: 5888521
    Abstract: The present invention relates to a composition for topical use comprising a hydroxycarboxylic acid and oat extract. The present invention also relates to a method of enhancing the rate of skin desquamation by incorporating oat extract into a composition containing hydroxycarboxylic acid. The composition can be topically applied.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: March 30, 1999
    Assignee: Amway Corporation
    Inventor: Amy C. Zimmerman
  • Patent number: 5888491
    Abstract: Coatings for hard tissue and surfaces of the oral environment are provided that reduce adhesion of bacteria and proteinaceous substances to these surfaces. Methods of reducing adhesion of these materials to such surfaces, and polymers for incorporation into such coatings are also provided.
    Type: Grant
    Filed: December 1, 1994
    Date of Patent: March 30, 1999
    Assignee: Minnesota Mining and Manufacturing Company
    Inventors: Sumita B. Mitra, Charles E. Shelburne, Sharon M. Rozzi, Brant L. Kedrowski
  • Patent number: 5888527
    Abstract: The present invention provides for an antifungal, antibacterial and antiviral filter comprising in laminations a dust collecting filter and a filter impregnated with a tea extract. The filter having nonwoven fabric is impregnated with a polyphenol tea extract, which can be easily produced commercially and is capable of maintaining a high virus trapping performance, inactivating the trapped viruses and preventing them from being rescattered.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: March 30, 1999
    Assignees: Matsushita Seiko Co., Ltd., Mitsui Norin Co., Ltd.
    Inventors: Kazuo Nashimoto, Yoshikazu Tashiro
  • Patent number: 5885594
    Abstract: The present invention relates to oral compositions having enhanced organoleptic characteristics of fattiness, creaminess, soothing, satisfaction, and full mouthfeel, and comprises acylglycerol compounds having substituents R.sub.1, R.sub.2, and R.sub.3 attached at the positions of the OH.sup.31 groups of a glycerol backbone. The substituents R.sup.1 and R.sub.2 are independently selected from conjugated polyunsaturated fatty acids having from 16 carbon atoms to 22 carbon atoms and R.sub.3 is selected from the group consisting of R.sub.1, OH, PO.sub.3 HR.sub.4, and C.sub.6 -C.sub.12 carboxylic acids, wherein R.sub.4 is selected from the group consisting of OH, choline, inositol, serine, and ethanolamine. The oral compositions of the present invention being substantially free of free conjugated polyunsaturated fatty acids.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: March 23, 1999
    Assignee: The Procter & Gamble Company
    Inventors: Stephen James Nilsen, Gary Lyle Walden
  • Patent number: 5885561
    Abstract: The wax combination for the cosmetic compositions contains from 2 to 70 percent by weight of apple wax; from 5 to 70 percent by weight of orange wax and/or citric wax; and from 10 to 70 percent by weight of jojoba oil. The cosmetic compositions advantageously contain a portion of the wax combination in free form or an effective ingredient complex consisting of capsules, each containing some of the wax combination.
    Type: Grant
    Filed: March 5, 1997
    Date of Patent: March 23, 1999
    Assignee: Wella Aktiengesellschaft
    Inventors: Ernst Flemming, Ursula Hehner, Karl-Heinz Kischka, Anke Jacobs, Rudolf Bimczok, Bianka Schmich
  • Patent number: 5885606
    Abstract: The present invention relates to a poison bait for controlling pest insects comprising (a) an insecticidally active ingredient, (b) a sauce for seasoning or a sauce spice flavor, (c) a vegetable oil and, if necessary, (d) at least one of grain powder, dextrin and sugar. The inventive poison bait controls pest insects such as cockroaches and the like based on feeding preference.
    Type: Grant
    Filed: December 14, 1995
    Date of Patent: March 23, 1999
    Assignee: Sumitomo Chemical Company, Limited
    Inventor: Hitoshi Kawada
  • Patent number: 5882666
    Abstract: It has long been the practice to treat the skin of individuals to clean and soften the skin with soaps and detergents. A compound containing glycerin, alcohol, jojoba oil, aloe vera, silk extracts, glyceryl monostearate, decyl oleate, propylene glycol, isopropyl palmitate, dimethicone, magnesium ascorbyl phosphate, sodium dodecyl sulfate, methyl paraben, xanthan gum, propyl paraben, and deionized water are formed into a silk cream composition in order to clean and soften skin. A lotion form of the compound that adds natural fragrances and mineral oil is also disclosed. A method of using the skin cream and or the lotion is also disclosed.
    Type: Grant
    Filed: November 20, 1997
    Date of Patent: March 16, 1999
    Inventors: Robert G. Averill, Miriam Averill
  • Patent number: 5882671
    Abstract: The present invention provides a method of treating anxiety and related disorders using an agonist which acts at negatively coupled cAMP-linked metabotropic glutamate receptors.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: March 16, 1999
    Assignee: Eli Lilly and Company
    Inventors: David Reed Helton, Mary Jeanne Kallman, James Allen Monn, Darryle Darwin Schoepp, Joseph Patrick Tizzano